The final approval from the United States Food and Drug Administration (USFDA) is to market Lansoprazole delayed release orally disintegrating tablets in the strengths of 15 mg and 30 mg, Zydus Cadila ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback